Results 151 to 160 of about 7,450 (200)

A New Class of Pathogenic Non-Coding Variants in GLA. [PDF]

Int J Mol Sci
Yuan Y, Zhang X, Ling C, Zhao Y, Yu M, Wang Z, Yuan Y, Xie Z, Zhang W.   +8 more
europepmc   +1 more source

Impact of migalastat on cerebral outcomes in fabry disease - results from the prospective observational FAMOUS trial. [PDF]

Neurol Res Pract
Choudhury M, Lenders M, Laufer P, Masthoff M, Canaan-Kühl S, Kurschat C, Muschol N, Hennermann JB, Cybulla M, Kaufeld J, Brand E, Bischof A.   +11 more
europepmc   +1 more source

High-Resolution Mass Spectrometry Method for Targeted Screening and Monitoring of Fabry, Gaucher and ASMD Using Dried Blood Spots and Capitainers: Impact of Sample Matrix on Measurement Results. [PDF]

Int J Mol Sci
Van Baelen A, Verhulst S, Eyskens F.
europepmc   +1 more source

Clinical outcomes in Fabry patients switching to agalsidase beta for renal ineffectiveness of the primary Fabry therapy: a single-centre analysis. [PDF]

Clin Kidney J
Riccio E, Capuano I, Buonanno P, Iaccarino G, Cirami CL, Mignani R, Pieruzzi F, Pisani A.   +7 more
europepmc   +1 more source

Untargeted Lipidomics in Fabry Disease of Urine Samples by Low-Resolution Flow Injection Mass Spectrometry (ESI(±)-LTQ MS). [PDF]

ACS Omega
Foletto RA, Borges AS, Motta L, Lyrio MVV, Baretto CT, Campos LCG, Filgueiras PR, Barauna VG, Romão W.   +8 more
europepmc   +1 more source

Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial. [PDF]

Clin Transl Med
Khan A, Barber DL, McKillop WM, Rupar CA, Auray-Blais C, Fraser G, Fowler DH, Berger A, Foley R, Keating A, West ML, Medin JA.   +11 more
europepmc   +1 more source

Terapia enzimatica sostitutiva nella malattia di Fabry: cosa abbiamo imparato dallo switch?

, 2014
Pisani, Antonio, Riccio, Eleonora
core  

Status and frontiers of Fabre disease. [PDF]

Orphanet J Rare Dis
Chu W, Chen M, Lv X, Lu S, Wang C, Yin L, Qian L, Shi J.   +7 more
europepmc   +1 more source

The Bacterium <i>P. aeruginosa</i> Disperses Ordered Membrane Domains by Targeting Phase Boundaries. [PDF]

Biomolecules
Stober K, Schwerdtfeger F, Aigal S, Mely Y, Römer W.   +4 more
europepmc   +1 more source